Art

J-GLOBAL ID：200902272172602314   Reference number：08A0285481

Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole

臨床医療における侵襲性真菌感染の治療: ボリコナゾールの常用量設定,治療適応,有効性及び安全性に関する多施設調査

Author (9)： VEHRESCHILD Joerg J. (Univ. Koeln, Koeln, DEU) ,  BOEHME Angelika (Johann Wolfgang Goethe-Univ. Frankfurt, Frankfurt am Main, DEU) ,  REICHERT Dietmar (Staedtische Kliniken Oldenburg, Oldenburg, DEU) ,  KIEHL Michael G. (Klinikum Frankfurt/Oder, Frankfurt an der Oder, DEU) ,  ARENZ Dorothee (Univ. Koeln, Koeln, DEU) ,  PANKRAZ Karen (Univ. Koeln, Koeln, DEU) ,  KOCHANEK Matthias (Univ. Koeln, Koeln, DEU) ,  ULLMANN Andrew J. (Johannes-Gutenberg-Univ. Mainz, Mainz, DEU) ,  CORNELY Oliver A. (Univ. Koeln, Koeln, DEU)
Material： International Journal of Hematology  (Int J Hematol)
Volume： 87  Issue： 2  Page： 126-131  Publication year： Mar. 2008 
JST Material Number： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： infection ,...
Semi thesaurus term： therapeutic indication ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0285481&from=J-GLOBAL&jstjournalNo=F0888A") }}

JST classification (2)： Clinical application of antifungal drugs  (GW17070V) ,  Treatment for infectious diseases,parasitic diseases.  (GD01030D)

Substance index (1)： Voriconazole

Reference (25)：

• DENNING, DW. Invasive aspergillosis. Clin Infect Dis. 1998, 26, 4, 781-803
• KLIMOWSKI, LL. Incidence of nosocomial aspergillosis in patients with leukemia over a 20-year period. Infect Control Hosp Epidemiol. 1989, 10, 7, 299-305
• ROTSTEIN, C. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients : benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clin Infect Dis. 1999, 28, 2, 331-340
• WINSTON, DJ. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med. 1993, 118, 7, 495-503
• PFALLER, MA. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J Clin Microbiol. 2003, 41, 1, 78-83

Terms in the title (9)： 臨床医療 ,  侵襲性真菌感染 ,  治療 ,  ボリコナゾール ,  常用量 ,  治療適応 ,  有効性 ,  安全性 ,  多施設調査